Video
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, talks about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.
Vegim Zhaku, from Tetovo University Faculty of Medicine, Macedonia, discussed the case of a male patient with palpitations, shortness of breath, epigastric discomfort and flatulence.
Sara Deleu, researcher at KU Leuven, talks about the role of gut metabolite, as Butyric acid and other compounds, during the fecal microbiota transplantation.
George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.
Iris Dothan, from Rabin Medical Center, Israel, talks about the profiling of patient with pouchitis in order to determine the benefits from microbiome manipulation.
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, talks about the donor-based microbiome therapeutic products research and development.
Elisa Cirillo, team lead research data manager at The Hyve, talks about the importance of having high quality data and strong tools to improve the microbiome research and business.
Jeroen Raes, from KU Leuven, Belgium, talks about the design of clinical trials for IBD patient with microbiome based therapies.
